On this page
MGP
matrix Gla protein
MGP is located on the short (p) arm of chromosome 12, at band 12p12.3. Arm ratio per GRCh38 - banding schematic.
Explore chromosome 12 in the library →Available at Jeen Health
Clinical tests that include this
Overview
MGP is situated on chromosome 12 at position 12p12.3. The gene directs the synthesis of matrix Gla protein, a secreted molecule. Research into this protein has explored its potential involvement in tissue calcium metabolism, though many aspects of its precise biological roles remain under active investigation. The name 'matrix Gla protein' reflects the presence of gamma-carboxyglutamic acid residues in the encoded molecule, a feature shared with other vitamin K-dependent proteins in human biology.
What the gene does
The protein encoded by MGP is secreted into the extracellular environment. Scientific studies have investigated how this protein may interact with calcium ions and participate in pathways related to tissue mineralisation, though the complete picture of its biological activities is still being assembled through ongoing research. The protein belongs to a family of molecules that contain gamma-carboxyglutamic acid residues, which are created through post-translational modification processes involving vitamin K as a cofactor. These chemical modifications appear to influence how the protein interacts with mineral components in various tissue environments.
Video: Genetics 101
Chromosome location
The MGP gene maps to chromosomal band 12p12.3 on the short arm of chromosome 12. This cytogenetic location places the gene in a specific region of the genome that can be identified through standard chromosome banding techniques.
Protein structure
The protein product of MGP is classified as a secreted protein according to UniProt reference P08493. Detailed structural domain architecture has not been fully characterised for this molecule. The protein contains residues that undergo specific chemical modifications, though comprehensive experimental mapping of all structural features remains an area of ongoing research.
Key variants
Genetic variation within the MGP sequence has been studied in various research contexts. Some investigations have examined whether particular sequence differences might associate with health outcomes, though such studies have yielded mixed results across different populations and study designs. The clinical significance of most MGP variants remains uncertain, and genetic testing for this gene is not part of routine clinical practice in the UK healthcare system.
Sample of pathogenic variants
4 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.
| Variant (HGVS) | Protein change | Classification | Evidence | Associated condition |
|---|---|---|---|---|
c.94+1G>A | - | Pathogenic/Likely pathogenic | ★★☆☆ | Keutel syndrome |
c.43del | p.Ala14_Val15insTer | Pathogenic | - | Keutel syndrome |
c.62-2A>G | - | Pathogenic | - | Keutel syndrome |
c.87T>A | p.Tyr29Ter | Pathogenic | - | Keutel syndrome |
Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.
Associated conditions
Research has explored potential connections between MGP and certain health conditions, particularly those involving tissue calcium metabolism. However, the gene is not currently included in standard clinical genetic testing panels used by the NHS Genomic Medicine Service. The inheritance pattern for any conditions potentially linked to MGP may vary depending on the specific genetic context and phenotype under consideration.
No disease links recorded for this gene in our reference set.
UK clinical status
MGP is not currently part of the NHS Genomic Medicine Service pathways or standard clinical genetic testing panels available through the UK healthcare system. Genetic analysis of this gene is generally performed in research settings rather than routine clinical care.
Sources: NHS GMS PanelApp · Genomics England PanelApp · NHS National Genomic Test Directory
Diet & lifestyle considerations
No specific lifestyle interventions targeting MGP function have been established through clinical trials. Population-level studies have examined dietary factors related to vitamin K intake and cardiovascular health, but these investigations have not yielded clear, actionable recommendations specific to MGP genotype. Individuals interested in cardiovascular health should follow general evidence-based guidance provided by healthcare professionals rather than focusing on any single gene.
Supplement considerations
Some research has investigated vitamin K and its potential role in vascular health, given that vitamin K serves as a cofactor for certain protein modifications. However, there is no conclusive evidence that vitamin K supplementation prevents specific conditions related to MGP or that supplementation should be tailored to MGP genotype. Anyone considering vitamin K supplements should discuss this with their GP or a registered dietitian, as vitamin K can interact with anticoagulant medications and individual nutritional needs vary considerably.
Frequently asked questions
What does the MGP gene do?
The MGP gene encodes matrix Gla protein, a secreted molecule. Scientific research suggests this protein may participate in pathways related to tissue calcium metabolism, though many details about its precise biological roles remain under investigation.
Where is the MGP gene located?
MGP is positioned on chromosome 12 at cytogenetic band 12p12.3, on the short arm of the chromosome. This location can be identified using standard chromosome mapping techniques.
Is MGP included in NHS genetic testing?
No, MGP is not currently part of standard NHS Genomic Medicine Service testing panels. Genetic analysis of this gene is typically performed in research contexts rather than routine clinical care.